Peritoneal Dialysis for Patients with Autosomal Dominant Polycystic Kidney Disease. Issue 4 (July 2017)

• Record Type: Journal Article
• Authors: Khan, Sana; Giuliani, Anna; Crepaldi, Carlo; Ronco, Claudio; Rosner, Mitchell H.
• Is Part Of: Peritoneal dialysis international. Volume 37:Issue 4(2017)
• Page Start: 384
• Page End: 388
• Publication Date: 2017-07
• Subjects: Peritoneal dialysis -- autosomal dominant poly-cystic kidney disease -- complications; Peritoneal dialysis -- Periodicals; Continuous ambulatory peritoneal dialysis -- Periodicals; 617.461059
• DOI: 10.3747/pdi.2016.00273
• Languages: English
• ISSNs: 0896-8608

Abstract

End-stage renal disease secondary to autosomal dominant poly-cystic kidney (ADPKD) is a common issue worldwide. Peritoneal dialysis (PD) is a reasonable option for renal replacement therapy for these patients and should not be withheld due to concerns that the patient may not tolerate the fluid volumes in the peritoneal cavity. This review covers the existing data on the outcomes and complications associated with the use of PD in the polycystic kidney disease patient. In general, PD is well tolerated and outcomes in ADPKD patients are equivalent to or better than other patient groups.